Free California Courts of Appeal case summaries from Justia.
If you are unable to see this message, click here to view it in a web browser. | | California Courts of Appeal June 4, 2020 |
|
|
Click here to remove Verdict from subsequent Justia newsletter(s). | New on Verdict Legal Analysis and Commentary | |
California Courts of Appeal Opinions | People v. Sanchez | Docket: F076908(Fifth Appellate District) Opinion Date: June 3, 2020 Judge: Jennifer R.S. Detjen Areas of Law: Criminal Law | The Court of Appeal affirmed the trial court's judgment in an action where defendant entered a West plea to involuntary manslaughter and child endangerment with great bodily injury. The court held that the jury verdict of not guilty of murder did not preclude, on collateral estoppel grounds, a second trial on assault on a child causing death because the jury's verdict did not necessarily resolve an ultimate fact in defendant's favor as to the latter; the People's amendment to the information to add a charge of child endangerment with enhancements for personally inflicting great bodily injury did not give rise to a presumption of vindictiveness; and Penal Code section 654 did not preclude a subsequent trial on the first amended information. | | Risperdal and Invega Cases | Dockets: B284002(Second Appellate District) , B284315(Second Appellate District) , B284317(Second Appellate District) Opinion Date: June 3, 2020 Judge: Dhanidina Areas of Law: Drugs & Biotech | Plaintiffs, two adolescents who were prescribed the antipsychotic drug risperidone after it was approved by the FDA to treat behavioral symptoms in children with autism, filed suit against Janssen for failure to adequately warn of the risk of gynecomastia on the drug's label. In the published portion of the opinion, the Court of Appeal held that the trial court was correct to decide the issue of preemption without submitting any purported underlying factual questions to a jury. The court also held that Janssen did not meet its burden to establish its preemption defense and that plaintiffs' claims based on the information in table 21, studies 41 and 70, are not preempted. In this case, Janssen did not meet its burden to show by clear evidence that it fully informed the FDA and, in turn, the FDA rejected a proposed label change. | | Nicole G. v. Braithwaite | Docket: B294228(Second Appellate District) Opinion Date: June 3, 2020 Judge: Stratton Areas of Law: Family Law | After a trial on both parties' domestic violence restraining order (DVRO) requests, the trial court denied Warren's requested DVRO and granted Nicole's requested DVRO against Warren. Warren appealed, arguing that the trial court erred by ordering him to move out of the property and by awarding use and possession of the property to Nicole. The Court of Appeal affirmed the trial court's order, holding that the Domestic Violence Prevention Act and Family Code sections 6340, 6321, and 6324 authorize a court to order the restrained party to move out of property and allow the protected party to use and possess the property. In this case, while ownership of the property will be determined in the pending civil suit, the trial court had authority to make orders about the use and possession of the property. The court concluded that the DVRO, including the move-out order and use/possession order, did not exceed the bounds of reason. | |
|
About Justia Opinion Summaries | Justia Daily Opinion Summaries is a free service, with 68 different newsletters, covering every federal appellate court and the highest courts of all US states. | Justia also provides weekly practice area newsletters in 63 different practice areas. | All daily and weekly Justia newsletters are free. Subscribe or modify your newsletter subscription preferences at daily.justia.com. | You may freely redistribute this email in whole. | About Justia | Justia is an online platform that provides the community with open access to the law, legal information, and lawyers. |
|
|